UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.201

Sortiert nach

PASI90 response: the new standard in therapeutic efficacy for psoriasis

Journal of the European Academy of Dermatology and Venereology, 2015-04, Vol.29 (4), p.645-648

Puig, L.

2015

Volltextzugriff (PDF)

Head‐to‐head comparison of biologics in psoriasis: better acceleration does not necessarily win all races

British journal of dermatology (1951), 2021-06, Vol.184 (6), p.992-993

Puig, L.

2021

Volltextzugriff (PDF)

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment

Journal of the European Academy of Dermatology and Venereology, 2011-09, Vol.25 (9), p.1007-1011

Puig, L.

2011

Volltextzugriff (PDF)

Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4‐week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?

British journal of dermatology (1951), 2020-02, Vol.182 (2), p.271-272

Puig, L.

2020

Volltextzugriff (PDF)

Significant weight loss improves and prevents psoriasis and psoriatic arthritis in obese patients: a Critically Appraised Topic and a call to action

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.884-885

Puig, L.

2019

Volltextzugriff (PDF)

British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infections

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.257-258

Puig, L.

2019

Volltextzugriff (PDF)

Epidemiology of atopic dermatitis in adults: Results from an international survey

Allergy (Copenhagen), 2018-06, Vol.73 (6), p.1284-1293

2018

Volltextzugriff (PDF)

Choice of first‐line biologic therapy in psoriasis: understanding the past and shaping the future?

British journal of dermatology (1951), 2017-09, Vol.177 (3), p.623-624

Puig, L.

2017

Volltextzugriff (PDF)

Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis

Actas dermo-sifiliográficas (English ed.), 2021-03, Vol.112 (3), p.203-215

Puig, L

2021

Volltextzugriff (PDF)

Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis

Actas dermo-sifiliográficas (English ed.), 2021-03, Vol.112 (3), p.203-215

Puig, L.

2021

Volltextzugriff (PDF)

Registries and biologics: disease populations matter

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.567-568

Puig, L.

2017

Volltextzugriff (PDF)

Interleukin-17 in skin: psoriasis and yonder

British journal of dermatology (1951), 2016-11, Vol.175 (5), p.859-860

Puig, L.

2016

Volltextzugriff (PDF)

Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management

British journal of dermatology (1951), 2017-07, Vol.177 (1), p.47-62

2017

Volltextzugriff (PDF)

European consensus statement on phenotypes of pustular psoriasis

Journal of the European Academy of Dermatology and Venereology, 2017-11, Vol.31 (11), p.1792-1799

2017

Volltextzugriff (PDF)

Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018

Actas dermo-sifiliográficas (English ed.), 2019-09, Vol.110 (7), p.517-518

Puig, L.

2019

Volltextzugriff (PDF)

Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018

Actas dermo-sifiliográficas (English ed.), 2019-09, Vol.110 (7), p.517-518

Puig, L

2019

Volltextzugriff (PDF)

Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons

Actas dermo-sifiliográficas (English ed.), 2019-09, Vol.110 (7), p.518-519

Puig, L.

2019

Volltextzugriff (PDF)

Análisis del coste incremental por respondedor (PASI75, PASI90 y PASI100) basado en un metaanálisis en red de tratamientos biológicos para la psoriasis: España 2018

Actas dermo-sifiliográficas, 2019-09, Vol.110 (7), p.517-518

Puig, L

2019

Volltextzugriff (PDF)

Patient reported outcomes en psoriasis validados en España: PROs y contras

Actas dermo-sifiliográficas, 2019-09, Vol.110 (7), p.518-519

Puig, L

2019

Volltextzugriff (PDF)

Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons

Actas dermo-sifiliográficas (English ed.), 2019-09, Vol.110 (7), p.518-519

Puig, L

2019

Volltextzugriff (PDF)

Biosimilars in psoriasis 2015: what is next?

Journal of the European Academy of Dermatology and Venereology, 2016-03, Vol.30 (3), p.467-469

Puig, L.

2016

Volltextzugriff (PDF)

A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain

PloS one, 2015-05, Vol.10 (5), p.e0127102

2015

Volltextzugriff (PDF)

Defining effective approaches to the reduction or elimination of biologic therapy immunogenicity and loss of response

Journal of the European Academy of Dermatology and Venereology, 2016-02, Vol.30 (2), p.321-323

Puig, L.

2016

Volltextzugriff (PDF)

Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity

PloS one, 2012-01, Vol.7 (1), p.e30378

2012

Volltextzugriff (PDF)

The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis

Journal of the European Academy of Dermatology and Venereology, 2017-10, Vol.31 (10), p.1616-1626

2017

Volltextzugriff (PDF)

1 – 25 von 4.201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.500)
Mit Volltextzugriff
(3.592)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.905)
Ingenta
(1.899)
Free E-Journal (出版社公開部分のみ）
(1.844)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1.322)
ScienceDirect
(1.239)
IngentaConnect Journals
(746)
Wiley Online Library
(637)
Wiley Online Library Full Collection 2018
(485)
NUS Single-Journal Subscriptions
(468)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(448)
SpringerLink_现刊
(242)
Oxford Journals
(225)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(149)
Springer Nature - Connect here FIRST to enable access
(135)
JSTOR
(122)
BMJ
(100)
Oxford Journals 2020 Medicine
(91)
Nexis Uni
(85)
BMJ Journals Archiv - DFG Nationallizenzen
(75)
Taylor & Francis
(72)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(30)

Menü

Weitere Dienste

Einstellungen

PASI90 response: the new standard in therapeutic efficacy for psoriasis

Head‐to‐head comparison of biologics in psoriasis: better acceleration does not necessarily win all races

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment

Psoriasis Area and Severity Index vs. pharmacokinetics: can monitoring 4‐week postinjection ustekinumab concentrations in patients with suboptimal response be clinically relevant?

Significant weight loss improves and prevents psoriasis and psoriatic arthritis in obese patients: a Critically Appraised Topic and a call to action

British Association of Dermatologists Biologic Interventions Register delivers: infliximab increases risk of serious infections

Epidemiology of atopic dermatitis in adults: Results from an international survey

Choice of first‐line biologic therapy in psoriasis: understanding the past and shaping the future?

Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis

Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis

Registries and biologics: disease populations matter

Interleukin-17 in skin: psoriasis and yonder

Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin‐17 inhibitors and their practical management

European consensus statement on phenotypes of pustular psoriasis

Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018

Incremental Cost per Responder (PASI-75, PASI-90 and PASI-100) Based on a Network Meta-Analysis of Biologic Therapies for Psoriasis: Spain 2018

Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons

Análisis del coste incremental por respondedor (PASI75, PASI90 y PASI100) basado en un metaanálisis en red de tratamientos biológicos para la psoriasis: España 2018

Patient reported outcomes en psoriasis validados en España: PROs y contras

Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons

Biosimilars in psoriasis 2015: what is next?

A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain

Defining effective approaches to the reduction or elimination of biologic therapy immunogenicity and loss of response

Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity

The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis

Suchergebnisse filtern